Jubilant arm develops oral Remdesivir to treat Covid
By IANS |
4 Views
How remdesivir can save lives in nations with lower hospital capacity.. Image Source: IANS News
Bengaluru, April 19 : Drug maker Jubilant Pharmova s subsidiary Jubilant Pharma on Monday said it has developed an oral formulation of remdesivir for non-invasive treatment of coronavirus. We have completed safety trials of the oral formulation of remdesivir by administering it to animals and human volunteers in the country, said the company in a statement here.
The Noida-based drug firm has a production plant near Mysuru.
The company has applied to regulator, the Drug Controller General of India for authorisation to conduct additional trials of the novel formulation.
Welcome To IANS Live - NATION - Jubilant arm develops oral Remdesivir to treat Covid
ianslive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ianslive.in Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma brings novel oral formulation of Remdesivir
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.